CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axoft, a neurotechnology company, today announced the approval of its first-in-human clinical study, which will take place in early 2025 at The Panama Clinic. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback